AstraZeneca PLC
Market Cap
$148.95B
P/E Ratio
29.43
EPS
$6.53
Dividend Yield
1.63%
52-Week Range
$122.48 — $212.71
Volume
988.03K
Avg Volume
3.09M
Beta
0.23
P/E (TTM)
29.43
Forward P/E
18.70
PEG Ratio
3.18
P/S (TTM)
5.07
P/B (TTM)
6.19
P/FCF
52.85
EV/EBITDA
50.48x
EV/Sales
—
ROE (TTM)
0.23%
ROA (TTM)
0.09%
ROIC
0.04%
Gross Margin
0.78%
Operating Margin
0.23%
Net Margin
0.17%
Debt/Equity
0.61
Current Ratio
0.94
EPS Growth (YoY)
+0.71%
Revenue Growth (YoY)
+0.08%
EPS Growth (3Y)
+0.77%
EPS Growth (5Y)
+5.37%
Sales Growth (3Y)
+0.10%
Sales Growth (5Y)
+0.18%
EPS Est (This Year)
$10.27
EPS Est (Next Year)
$11.54
Dividend Yield
—
Annual Dividend
$0.52
Payout Ratio
0.64%
Frequency
—
Ex-Dividend Date
2025-08-08
Cash/Share
$3.70
Sell
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $105.50(-45.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
3.10B
Float
3.09B
Free Float %
99.57%
RSI (14)
65.83
SMA 20
$200.71
SMA 50
$190.93
SMA 200
$167.77
ATR (14)
4.83
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
—
1 Day
-0.97%
1 Week
-2.35%
1 Month
+7.84%
3 Months
+9.81%
6 Months
+25.22%
1 Year
—
YTD
+10.44%
All-Time High
$205.86
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
GB
Exchange
NYSE
IPO Date
1993-05-12
Employees
94300
CEO
Pascal Claude Roland Soriot
Index Membership
—
Website
https://www.astrazeneca.com
AstraZeneca PLC (AZN) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $148.95B, a P/E ratio of 29.43, and a dividend yield of 1.63%, AZN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AZN against other stocks using dozens of fundamental and technical filters.
AstraZeneca PLC (AZN) has a trailing twelve-month (TTM) P/E ratio of 29.43. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AstraZeneca PLC (AZN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AstraZeneca PLC (AZN) has a market capitalization of $148.95 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Sell" rating on AstraZeneca PLC (AZN) with an average score of 4.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $105.50 implies 45.1% downside from the current price.
AstraZeneca PLC (AZN) has returned +10.44% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.